The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
The American Journal of Clinical Nutrition , 87(1), 155S158S
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) are approved for type 2 diabetes and obesity, not Hashimoto's thyroiditis
Other medications like Xenical, which reduces the absorption of fat, may be a good fit for people who are looking to reduce their calorie intake or who might not tolerate the GLP-1 drugs
Both lower glucose, so monitoring for hypoglycemia is important
Knowing that, she says, reduced her sense of stigma and helped her find the most fitting combination of medications for her